Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

Clinical trial NCT03834961 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03834961
Sponsor: Children's Oncology Group
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Central Nervous System Neoplasm Infantile Fibrosarcoma Recurrent Acute Leukemia Refractory Acute Leukemia Solid Neoplasm

Start date: 2019-10-25
Primary completion: 2024-09-30
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.